← FDA DRUG APPROVALS

FDA ANDA · ANDA072437

FENOPROFEN CALCIUM

Sponsor: PAR PHARM

APPLICATION
ANDA072437
TYPE
ANDA
ORIGINAL APPROVAL
1988-08-22
LATEST ACTION
1991-05-31
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

FENOPROFEN CALCIUMDiscontinued
FENOPROFEN CALCIUM EQ 200MG BASE · CAPSULE · ORAL

Approval history

1991-05-31Labeling · Supplement 5AP
1989-05-12Labeling · Supplement 4AP
1989-03-31Labeling · Supplement 3AP
1988-08-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →